AstraZeneca has made a preliminary approach to rival drugmaker Gilead Sciences about a potential merger, as per sources in what would be the biggest healthcare deal on record. The UK-based firm informally contacted Gilead last month to gauge its interest in a possible tie-up, said sources, who added that AstraZeneca didn’t specify terms for any transaction.
Want to know more on AstraZeneca eyes record pharma merger with Gilead click here go to market news source.
Market news summary from The Times of India Market News.Author: …
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.